CoronaVac

CoronaVac is an inactivated vaccine for COVID-19 developed by Sinovac. It relies on traditional technology similar to the influenza (flu) vaccine and hepatitis A vaccine.

Overview

CoronaVac is a two-dose vaccine, with each dose given two weeks apart. It is stored at normal fridge temperatures and is therefore easier to transport and store than some other COVID-19 vaccines.

Efficacy

The efficacy of CoronaVac varies depending on the population in which it is used. In Brazil, it was found to be 50.7% effective in preventing symptomatic infections, while in Indonesia, it was 65.3% effective. In Turkey, the efficacy was reported to be 83.5%.

Side Effects

Common side effects of CoronaVac include pain at the injection site, fatigue, muscle pain, and fever. Serious side effects are rare.

Approval

As of July 2021, CoronaVac has been approved for emergency use in over 40 countries.

See Also

• COVID-19 vaccine
• Sinovac
• Inactivated vaccine

CoronaVac Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski